Blau Farmaceutica (BSP:BLAU3) Marketable Securities: R$838 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:BLAU3 Blau Farmaceutica SA BSP:BLAU3
84 GF Score
Price R$9.07
GF Value R$10.69
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Blau Farmaceutica Marketable Securities?

Blau Farmaceutica BSP:BLAU3 84 Marketable Securities is R$838 Mil as of Jun. 2026. GuruFocus rates BSP:BLAU3 with a GF Score™ of 84/100 and a GF Value™ of R$10.69 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Blau Farmaceutica's Marketable Securities for the quarter that ended in Jun. 2026 was R$838 Mil.

Blau Farmaceutica's annual Marketable Securities increased from Dec. 2023 (R$376 Mil) to Dec. 2024 (R$460 Mil) and increased from Dec. 2024 (R$460 Mil) to Dec. 2025 (R$569 Mil).

Blau Farmaceutica  (BSP:BLAU3) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Blau Farmaceutica Marketable Securities Related Terms

Blau Farmaceutica Marketable Securities Historical Data

* Premium members only.

The historical data trend for Blau Farmaceutica's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Blau Farmaceutica Marketable Securities Chart

Blau Farmaceutica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 870.96 629.53 375.82 459.56 569.49

Blau Farmaceutica Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 239.13 593.02 569.49 485.90 838.10
BSP:BLAU3
84GF Score
Blau Farmaceutica SA BSP:BLAU3
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Blau Farmaceutica Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of R$838 Mil mean?
Blau Farmaceutica (BSP:BLAU3) has a Marketable Securities of R$838 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Blau Farmaceutica and its competitors.
Is Blau Farmaceutica's Marketable Securities too high?
Blau Farmaceutica's current Marketable Securities is R$838 Mil. Overall, Blau Farmaceutica has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Blau Farmaceutica's Marketable Securities compare to ZTS and UTHR?
Blau Farmaceutica's Marketable Securities of R$838 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Blau Farmaceutica and its competitors. Blau Farmaceutica's current Marketable Securities is R$838 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blau Farmaceutica stock overvalued right now?
Based on GuruFocus' analysis, Blau Farmaceutica (BSP:BLAU3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$10.69, compared to a current price of R$9.07 — trading 15.2% below its estimated fair value. The current Marketable Securities is R$838 Mil. Blau Farmaceutica's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Blau Farmaceutica (BSP:BLAU3), the current Marketable Securities is R$838 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Blau Farmaceutica (BSP:BLAU3) Overvalued in 2026?

Based on GuruFocus' analysis, Blau Farmaceutica stock appears to be undervalued. The current stock price of R$9.07 is trading 15.2% below its estimated GF Value™ of R$10.69. GuruFocus considers Blau Farmaceutica to be Modestly Undervalued.

Key valuation signals for BSP:BLAU3:

  • Marketable Securities: R$838 Mil
  • GF Value™: R$10.69 vs. price of R$9.07 (15.2% below fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the BSP:BLAU3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Blau Farmaceutica Business Description

Address Rodovia Raposo Tavares, No. 2833, Km 30.5, Barro Branco, Cotia, SP, BRA, 06705-030
Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.
84GF Score

Get the complete analysis for BSP:BLAU3

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$9.07
Price
R$10.69
GF Value